The Energy Investor’s Guide To The Trump Presidency
Among the various policy areas that are about to undergo the most radical of shifts with the transfer of the executive branch from President Obama…
Among the various policy areas that are about to undergo the most radical of shifts with the transfer of the executive branch from President Obama…
In the current low interest-rate environment, dividend-paying stocks have been getting a lot of love from yield-starved investors. However, as today’s article emphasizes, 525 companies…
After being weighted down this year by the prospect of a Hillary Clinton administration focused on curbing drug prices, biotechs have seen a recovery since…
“There isn’t a day that goes by on Wall Street when certain stocks trading under $10 a share don’t experience massive spikes higher,” notes the…
“Value stocks are beating the pants off of growth stocks this year,” states the author of today’s article which examines the competition between these two…
While today’s article was written before the election and its shocking upset, the author had the foresight to ignore the polls, pundits and public expectations…
While it is widely agreed upon that a Hillary Clinton election victory would be bad news for pharmaceutical stocks due to her promise to tackle…
Whatever the results of the election Tuesday night (assuming there even are definitive results Tuesday night), the winners and losers will not be limited to…
With the S&P 500 having been on a tear since 2009, the author of today’s article makes note of a surprising fact: “In the past…
With nine states voting on November 8th to legalize marijuana for either medical or recreational purposes, marijuana stocks have been attracting a great deal of…